Continuous hyperfractionated accelerated radiotherapy (CHART) in non small cell lung cancer: A single centre experience as standard treatment

被引：0
|
作者：
Hatton, M [1 ]
Omar, D [1 ]
Fisher, P [1 ]
Peter, P [1 ]
Mohanamurali, K [1 ]
机构：
[1] Weston Pk Hosp, Sheffield, S Yorkshire, England
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)81211-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S307 / S307
页数：1
相关论文
共 50 条
  • [41] INDUCTION CHEMOTHERAPY AND CONTINUOUS HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (CHART) FOR PATIENTS WITH LOCALLY ADVANCED INOPERABLE NON SMALL-CELL LUNG CANCER: THE MRC INCH RANDOMIZED TRIAL
    Hatton, Matthew
    Nankivell, Matthew
    Lyn, Ethan
    Falk, Stephen
    Pugh, Cheryl
    Navani, Neal
    Stephens, Richard
    Parmar, Mahesh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (03): : 712 - 718
  • [42] Induction chemotherapy and continuous hyperfractionated accelerated radiotherapy (CHART) for patients with locally advanced inoperable non-small cell lung cancer: the MRC INCH randomised trial
    Matthew, Hatton
    Nankivell, Matthew G.
    Lyn, Ethan
    Falk, Stephen
    Pugh, Cheryl
    Navani, Neal
    Stephens, Richard
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S337 - S337
  • [43] PATTERNS OF RECURRENCE AFTER TREATMENT WITH CONTINUOUS HYPERFRACTIONATED ACCELERATED RADIATION THERAPY IN NON-SMALL CELL LUNG CANCER
    Walker, G.
    Muthukumar, D.
    Vijayan, R.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S55 - S55
  • [44] Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for NSCLC: experience from nine UK centres
    Bradshaw, A. G.
    Esler, C.
    Roy, A. E. F.
    Toy, E.
    Lester, J. F.
    Kinsman, J.
    Atherton, P.
    Knox, C.
    Walker, G. A.
    Hatton, M. Q.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S24 - S25
  • [45] Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer
    Zwitter, Mayaz
    Kovac, Vijem
    Smrdel, Uros
    Strojan, Primoz
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (07) : 662 - 666
  • [46] Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer: A competing risks analysis
    Ö U Ataman
    S M Bentzen
    M I Saunders
    S Dische
    British Journal of Cancer, 2001, 85 : 1113 - 1118
  • [47] Hyperfractionated Accelerated Radiotherapy Versus Stereotactic Body Radiotherapy in the Treatment of Limited-Stage Small Cell Lung Cancer
    Yang, Lujie
    Lu, Xianfeng
    Luo, Jiamin
    Huang, Danju
    Dai, Xiaoyan
    Yang, Yuxin
    Dai, Nan
    Xiong, Yanli
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (03): : 115 - 121
  • [48] Long term results of surgery versus continuous hyperfractionated accelerated radiotherapy (CHART) in patients aged >70 years with stage 1 non-small cell lung cancer
    Ghosh, S
    Sujendran, V
    Alexiou, C
    Beggs, L
    Beggs, D
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2003, 24 (06) : 1002 - 1007
  • [49] Hi-chart: A phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer
    De Ruysscher, Dirk
    Wanders, Rinus
    Van Haren, Erik
    Hochstenbag, Monique
    Geraedts, Wiel
    Pitz, Cordula
    Simons, Jean
    Boersma, Liesbeth
    Verschueren, Tom
    Minken, Andre
    Bentzen, Soren M.
    Lambin, Philippe
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (01): : 132 - 138
  • [50] Radiation Dose Escalation in Accelerated Hyperfractionated Radiotherapy for Stage III Non-small-cell Lung Cancer
    Wada, Kentaro
    Kishi, Noriko
    Kanayama, Naoyuki
    Hirata, Takero
    Morimoto, Masahiro
    Konishi, Koji
    Imamura, Fumio
    Teshima, Teruki
    Ogawa, Kazuhiko
    ANTICANCER RESEARCH, 2018, 38 (10) : 5951 - 5958
12345